npj Vaccines (Feb 2024)

MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques

  • Brandon J. Beddingfield,
  • Kenneth S. Plante,
  • Jessica A. Plante,
  • Scott C. Weaver,
  • Sarah Bose,
  • Clara Krzykwa,
  • Nicole Chirichella,
  • Rachel K. Redmann,
  • Stephanie Z. Seiler,
  • Jason Dufour,
  • Robert V. Blair,
  • Kathrin Endt,
  • Ariane Volkmann,
  • Nicholas J. Maness,
  • Chad J. Roy

DOI
https://doi.org/10.1038/s41541-024-00842-y
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 11

Abstract

Read online

Abstract MVA-based monovalent eastern equine encephalitis virus (MVA-BN-EEEV) and multivalent western, eastern, and Venezuelan equine encephalitis virus (MVA-BN-WEV) vaccines were evaluated in the cynomolgus macaque aerosol model of EEEV infection. Macaques vaccinated with two doses of 5 × 108 infectious units of the MVA-BN-EEEV or MVA-BN-WEV vaccine by the intramuscular route rapidly developed robust levels of neutralizing antibodies to EEEV that persisted at high levels until challenge at day 84 via small particle aerosol delivery with a target inhaled dose of 107 PFU of EEEV FL93-939. Robust protection was observed, with 7/8 animals receiving MVA-BN-EEEV and 100% (8/8) animals receiving MVA-BN-WEV surviving while only 2/8 mock vaccinated controls survived lethal challenge. Complete protection from viremia was afforded by both vaccines, with near complete protection from vRNA loads in tissues and any pathologic evidence of central nervous system damage. Overall, the results indicate both vaccines are effective in eliciting an immune response that is consistent with protection from aerosolized EEEV-induced disease.